Sentences with phrase «study on breast cancer»

Breast: Population studies on breast cancer related to dietary fiber and whole grains are more limited and mixed.

Meta - analysis of studies on breast cancer risk and diet in Chinese women.

Three recent studies on breast cancer survivors have all found that soy intake was associated with better survival — that is the just about the best evidence you are going to get of its safety.

The IF studies on breast cancer in the UK were All women and the benefits were identical as Varaday's except that they focused on cancer prevention instead of just weight loss.

Not exact matches

In 2015, researchers at the University of Washington's Cancer Vaccine Institute published a study on designing vaccines to prevent breast cCancer Vaccine Institute published a study on designing vaccines to prevent breast cancercancer.

In a chapter dedicated to the work of the Life charity, studies on the link between abortion and breast cancer are discussed, as are findings that show rates of suicide and binge drinking are higher among women who have had abortions.

While there are studies that show soy might have some benefits for older women such as lowering cholesterol, easing menopausal symptoms, and reducing risk of breast cancer, other research casts doubt on these findings.

There are a few ongoing studies trying to determine if breastfeeding has an impact on breast cancer risk reduction.

There's only one study that I am aware of that has looked at the impact of a decent length of breastfeeding on risk of breast cancer.

* «A case control study of the impact on breast cancer mortality of the East Anglian breast screening programme.»

The study, led by Dr Len Stephens and Dr Phill Hawkins and published today in the journal Molecular Cell, reveals why loss of the PTEN gene has such an impact on many people with prostate cancer, as well as in some breast cancers.

An earlier study that didn't take parental influence into account found one variant on chromosome 11 raised the risk of breast cancer by 7 per cent.

Vitamin C has previously been shown to be effective as a non-toxic anti-cancer agent in studies by Nobel Prize winner Linus Pauling and was recently shown to reduce mortality by 25 % on breast cancer patients in Japan.

In the second study, a team of Danish researchers wanted to test the effect of a change in alcohol intake on the risk of breast cancer and heart disease.

Bloch's colleagues at the National Institute of Environmental Health Sciences tested the oils in gene expression studies on lab - grown human breast cancer cells and found that they could mimic estrogens, the primary female sex hormones, and inhibit androgens, the primary male sex hormones.

Commenting on the results for ESMO, Dr Evandro de Azambuja, Head of the Medical Support Team, Academic Promoting Team, Jules Bordet Institute, Brussels, Belgium, said: «This study shows that it's not only tumour size that is important for breast cancer patients but also tumour biology.

Surgical oncologists, or cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,Cancer Center, Tampa, Fla..

In the current study, Zhang and her colleagues, including Esther John, Ph.D., senior cancer epidemiologist at the Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sincecancer epidemiologist at the Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sinceCancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sincebreast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sincecancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sinceBreast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sinceCancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families sinceCancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since 1995.

This review examines three areas of study — one, the biological pathways of alcohol - linked breast cancer; two, the epidemiological risk relationship between drinking and breast cancer; and three, the global burden of breast cancer incidence and mortality that is attributable to drinking — with a focus on light drinking.

ON THE ROAD Breast cancer cells may break away from the main tumor in clumps, already bearing most of the mutations that will drive cancer recurrence, a study suggests.

«There is currently no method that can predict treatment outcome of chemotherapy early on in treatment, so this is a major advance,» says Hielscher, co-leader of the study, who is also a member of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at NewYork - Presbyterian / Columbia University Irving Medical Center.

«Since epalrestat is already on the market and has no major adverse side effects, our study provides a proof of principle that it could become a valuable targeted drug for the clinical treatment of basal - like breast cancer,» Dong says.

The study, which compared each model's success in Caucasian women with those of Asian descent (Chinese, Japanese, Filipino, Korean and Vietnamese), also raised important questions about the effect of race on cancer development: When Caucasian and Asian patients with similar family histories of breast and ovarian cancer were compared, the Asian women had higher rates of genetic mutation, although the rates of these cancers for Asians have traditionally been lower.

To see whether cancer stem cell renewal involves a chain of events similar to that used by embryonic stem cells, and whether the process was affected by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two human breast cancer cell lines that responded to low oxygen by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.

For this study, Dr. Lou and his colleagues focused on triple - negative breast cancer, which is difficult to treat, because it does not exhibit receptors for estrogen, progesterone or the HER - 2 / neu gene, which are targets for many current breast cancer treatments.

Effect of exercise on weight, body fat, and serum inflammatory biomarkers in breast cancer survivors with aromatase inhibitor arthralgias (joint pain): The hormones and physical exercise (HOPE) study.

«Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit cancer metastasis in women with triple - negative breast cancer who are at highest risk for cancer metastasis.»

Witt - Enderby at Duquesne is using her expertise in molecular pharmacology to study the effects of melatonin on a mouse breast cancer model.

«The findings of both studies support a growing body of research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stcancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both studies.

Ana Soto, professor of cellular biology at Tufts University School of Medicine, and her colleagues were studying the effects of estrogen on a breast cancer cell line.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

Professor Doug Easton from the University of Cambridge, one of the lead investigators on the study, says: «These findings add significantly to our understanding of the inherited basis of breast cancer.

Lead author Moustafa Abdalla writes: «Almost all genomic studies of breast cancer have focused on well - established tumours because it is technically challenging to study the earliest mutational events occurring in human breast epithelial cells.»

The combination should be studied in other populations of patients, Adelson added, including those who are newly diagnosed with metastatic breast cancer and those who have already progressed on fulvestrant.

In the first study to report on the association of aspirin use with breast cancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative caCancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cancers.

The researchers have isolated the sesquiterpene lactone damsin from the plant and studied its effect on cancer stem cells in three different breast cancer cell lines.

The role of weight in ovarian - cancer risk emerges from an analysis of data on some 68,000 women participating in one of three major ongoing investigations: the New York (City) University Women's Health Study, the Northern Sweden Health and Disease Study in Umea, and the Diet in the Etiology of Breast Cancer Study in Milan, cancer risk emerges from an analysis of data on some 68,000 women participating in one of three major ongoing investigations: the New York (City) University Women's Health Study, the Northern Sweden Health and Disease Study in Umea, and the Diet in the Etiology of Breast Cancer Study in Milan, Cancer Study in Milan, Italy.

Professor Cornelis van de Velde, President of ECCO, said: «With the increase in incidence of both diabetes and breast cancer, this is an important update of the meta - analyses on this subject and an interesting addition to the literature as this study excluded other causes of death.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

ResearchKit already has five apps, live now, that link users to studies on Parkinson's disease, diabetes, asthma, breast cancer and heart disease.

As we are seeing more women survive breast cancer, we need to focus on long term survivorship issues and ensuring that women have access to this important part of treatment,» says study first author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Comprehensive Cancer Ccancer, we need to focus on long term survivorship issues and ensuring that women have access to this important part of treatment,» says study first author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Comprehensive Cancer CCancer Center.

In this study, the researchers tested the effects of Olaparib on the tumors formed by human breast cancer cells injected into mice.

Currently, in another study, the researchers are focused on detecting circulating tumor cells in the blood of patients with a diagnosis of breast cancer.

Harris estimates that about 20 studies suggest aspirin and similar drugs may have a preventive effect on breast cancer.

In a four - year study conducted on the mouse model in advanced breast cancer metastasis in the eye's anterior chamber, Petty and colleagues found that the new nanoparticle not only killed tumor cells in the eye, but also extended the survival of experimental mice bearing 4T1 tumors, a cell line that is extremely difficult to kill.

«It's incredibly encouraging to find possible new options for patients with an aggressive cancer like triple negative breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thcancer like triple negative breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thcancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thCancer Center, and former CEO of the ICR.

«Given that this technique helps to shield the heart during radiation treatment for breast cancer,» said Rani Anne, M.D., Associate Professor of Radiation Oncology at Thomas Jefferson University and senior author on the study, «we routinely offer breast cancer treatment with the breath hold technique at Jefferson.»

The authors believe theirs is the first study to show that mouse mammary gland tissues are sensitive to a mixture of 23 commonly used UOG chemicals, with dose - specific effects on tissue morphology, cell proliferation and induction of intraductal hyperplasias, an overgrowth of cells considered a marker for future breast cancer risk.

The scientists are planning further study of HOXA5's role in breast cancer, following up on this work and a study published by Sukumar's lab in 2000 that showed a connection between low levels of HOXA5 and the well - known tumor suppressor protein p53.

When it comes to two of the genes on the panel, BRCA1 and BRCA2, there's little doubt that in cancer - prone families, testing saves lives: Extensive study of BRCA carriers has found that those who have their ovaries removed are 80 % less likely to die from ovarian cancer and 50 % less likely to die from breast cancer.